Literature DB >> 7915197

Cell cycle arrest by Colcemid differs in human normal and tumor cells.

M N Jha1, J R Bamburg, J S Bedford.   

Abstract

In the continuous presence of Colcemid, the mitotic index in cultures of nine human tumor cell lines began to increase immediately upon addition of the drug. For 12 human normal (nontumorigenic) cell lines, the mitotic index did not begin to increase for some 2 to 3 h after the addition of Colcemid. The effect was independent of whether the cells were of fibroblast or epithelial origin and occurred over a 1000-fold range of Colcemid concentrations. No such differential effect was seen with single concentrations of either Taxol or nocodazole, but a similar delayed effect was seen for two concentrations of vinblastine. These observations suggest a fundamental difference between human normal and human tumor cells involving a cell cycle checkpoint in G2, about 1 to 2 h before mitosis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7915197

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  10 in total

1.  A new identity for MLK3 as an NIMA-related, cell cycle-regulated kinase that is localized near centrosomes and influences microtubule organization.

Authors:  Katherine I Swenson; Katharine E Winkler; Anthony R Means
Journal:  Mol Biol Cell       Date:  2003-01       Impact factor: 4.138

Review 2.  Safeguarding entry into mitosis: the antephase checkpoint.

Authors:  Cheen Fei Chin; Foong May Yeong
Journal:  Mol Cell Biol       Date:  2010-01       Impact factor: 4.272

3.  Inhibition of mixed-lineage kinase (MLK) activity during G2-phase disrupts microtubule formation and mitotic progression in HeLa cells.

Authors:  Hyukjin Cha; Surabhi Dangi; Carolyn E Machamer; Paul Shapiro
Journal:  Cell Signal       Date:  2005-05-31       Impact factor: 4.315

4.  Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity.

Authors:  J He; S Choe; R Walker; P Di Marzio; D O Morgan; N R Landau
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

5.  Revised genetic requirements for the decatenation G2 checkpoint: the role of ATM.

Authors:  Jacquelyn J Bower; Yingchun Zhou; Tong Zhou; Dennis A Simpson; Sonnet J Arlander; Richard S Paules; Marila Cordeiro-Stone; William K Kaufmann
Journal:  Cell Cycle       Date:  2010-04-15       Impact factor: 4.534

Review 6.  FHA-RING ubiquitin ligases in cell division cycle control.

Authors:  L Brooks; E G Heimsath; G L Loring; C Brenner
Journal:  Cell Mol Life Sci       Date:  2008-11       Impact factor: 9.261

7.  N-Formyl-7-amino-11-cycloamphilectene, a marine sponge metabolite, binds to tubulin and modulates microtubule depolymerization.

Authors:  Luigi Margarucci; Maria Chiara Monti; Roberta Esposito; Alessandra Tosco; Ernest Hamel; Raffaele Riccio; Agostino Casapullo
Journal:  Mol Biosyst       Date:  2014-02-04

8.  The checkpoint protein Chfr is a ligase that ubiquitinates Plk1 and inhibits Cdc2 at the G2 to M transition.

Authors:  Dongmin Kang; James Chen; Jim Wong; Guowei Fang
Journal:  J Cell Biol       Date:  2002-01-21       Impact factor: 10.539

9.  Tubulin mRNA stability is sensitive to change in microtubule dynamics caused by multiple physiological and toxic cues.

Authors:  Ivana Gasic; Sarah A Boswell; Timothy J Mitchison
Journal:  PLoS Biol       Date:  2019-04-09       Impact factor: 8.029

10.  CHIR99021, trough GSK-3β Targeting, Reduces Epithelioid Sarcoma Cell Proliferation by Activating Mitotic Catastrophe and Autophagy.

Authors:  Sabino Russi; Alessandro Sgambato; Anna Maria Bochicchio; Pietro Zoppoli; Michele Aieta; Alba Maria Lucia Capobianco; Vitalba Ruggieri; Emanuela Zifarone; Geppino Falco; Simona Laurino
Journal:  Int J Mol Sci       Date:  2021-10-15       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.